Chancery Tosses Remainder Of Suit Against Vaccine Firm
By Leslie A. Pappas ( June 3, 2022, 9:31 PM EDT) -- The Delaware Chancery Court on Friday dismissed the remaining counts of a stockholder suit alleging that company directors and a major shareholder of California biotech firm Vaxart Inc. wrongly profited from nonpublic information about efforts to develop a COVID-19 vaccine....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.